Keyan Yang
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Clinical features, mutational landscape and their prognostic impact in Chinese paediatric patients with T-cell lymphoblastic lymphoma.
Journal: British journal of haematology
Published: March 17, 2025
Activity of trametinib as maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory RAS pathway-mutated hematologic malignancies.
Journal: Annals of hematology
Published: June 12, 2024
CD7 CART Therapy Bridging Allo-HSCT Remarkably Improves Long-Term DFS in Refractory/Relapsed T-ALL/LBL.
Journal: Transplantation and cellular therapy
Published: May 07, 2024
Identifying risk factors for severe omicron infection in allogeneic hematopoietic stem cell transplant recipients with hematologic malignancies.
Journal: Cancer reports (Hoboken, N.J.)
Published: January 21, 2024
Impact of ARID1A and TP53 mutations in pediatric refractory or relapsed mature B-Cell lymphoma treated with CAR-T cell therapy.
Journal: Cancer cell international
Published: August 18, 2023
Poor outcome of pediatric B-cell acute lymphoblastic leukemia associated with high level of CRLF2 gene expression in distinct molecular subtypes.
Journal: Frontiers in oncology
Published: July 10, 2023
CAR-T therapy followed by allogeneic hematopoietic stem cell transplantation for refractory/relapsed acute B lymphocytic leukemia: Long-term follow-up results.
Journal: Frontiers in oncology
Published: September 19, 2022
Donor CD7 Chimeric Antigen Receptor T Cell Bridging to Allogeneic Hematopoietic Stem Cell Transplantation for T Cell Hematologic Malignancy.
Journal: Transplantation and cellular therapy
Published: August 01, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026